Kim YH - Search Results

1

Accuracy and Prognostic Significance of Oncologists' Estimates and Scenarios for Survival Time in Advanced Gastric Cancer.

Vasista A, Stockler M, Martin A, Pavlakis N, Sjoquist K, Goldstein D, Gill S, Jain V, Liu G, Kannourakis G, Kim YH, Nott L, Snow S, Burge M, Harris D, Jonker D, Chua YJ, Epstein R, Bonaventura A, Kiely B. Vasista A, et al. Among authors: kim yh. Oncologist. 2019 Nov;24(11):e1102-e1107. doi: 10.1634/theoncologist.2018-0613. Epub 2019 Apr 1. Oncologist. 2019. PMID: 30936377 Free PMC article. Clinical Trial.

2

A prognostic model to identify patients with advanced pancreas adenocarcinoma who could benefit from second-line chemotherapy.

Kim ST, Choi YJ, Park KH, Oh SC, Seo JH, Shin SW, Kim JS, Kim YH. Kim ST, et al. Among authors: kim yh, kim js. Clin Oncol (R Coll Radiol). 2012 Mar;24(2):105-11. doi: 10.1016/j.clon.2011.02.005. Epub 2011 Mar 5. Clin Oncol (R Coll Radiol). 2012. PMID: 21382702

3

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.

Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A; FOXFIRE trial investigators; SIRFLOX trial investigators; FOXFIRE-Global trial investigators; van Hazel G, Sharma RA. Wasan HS, et al. Lancet Oncol. 2017 Sep;18(9):1159-1171. doi: 10.1016/S1470-2045(17)30457-6. Epub 2017 Aug 3. Lancet Oncol. 2017. PMID: 28781171 Free PMC article. Clinical Trial.

4

Martin AJ, Gibbs E, Sjoquist K, Pavlakis N, Simes J, Price T, Shannon J, Gill S, Jain V, Liu G, Kannourakis G, Kim YH, Kim JW, Goldstein D; INTEGRATE I investigators. Martin AJ, et al. Among authors: kim yh, kim jw. Gastric Cancer. 2018 May;21(3):473-480. doi: 10.1007/s10120-017-0754-1. Epub 2017 Aug 16. Gastric Cancer. 2018. PMID: 28815316 Clinical Trial.

5

Prospective analysis of treatment outcome and prognostic factors in patients with T-cell lymphomas treated by CEOP-B: single institutional study.

Sung HJ, Kim SJ, Seo HY, Sul HR, Choi JG, Choi IK, Park KH, Oh SC, Seo JH, Choi CW, Kim BS, Shin SW, Kim YH, Kim JS. Sung HJ, et al. Among authors: kim yh, kim bs, kim sj, kim js. Br J Haematol. 2006 Jul;134(1):45-53. doi: 10.1111/j.1365-2141.2006.06124.x. Br J Haematol. 2006. PMID: 16803566 Free article.

6

Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial.

Kim YH, Yamaguchi K, Bang YJ, Takiuchi H, Kang WK, Sato A, Kang YK, Sakamoto J, Abe C, Sakata Y. Kim YH, et al. Jpn J Clin Oncol. 2007 Jul;37(7):501-8. doi: 10.1093/jjco/hym054. Epub 2007 Aug 2. Jpn J Clin Oncol. 2007. PMID: 17673470 Clinical Trial.

7

Phase I dose escalation study of docetaxel with a fixed dose of S-1 in combination chemotherapy for advanced gastric cancer.

Kim YH, Seo HY, Jeen YT, Kim HK, Shim BY, Yang J. Kim YH, et al. Among authors: kim hk. Cancer Chemother Pharmacol. 2009 Jan;63(2):253-60. doi: 10.1007/s00280-008-0734-6. Epub 2008 May 21. Cancer Chemother Pharmacol. 2009. PMID: 18493761 Clinical Trial.

8

Prognostic significance of serum vascular endothelial growth factor per platelet count in unresectable advanced gastric cancer patients.

Seo HY, Park JM, Park KH, Kim SJ, Oh SC, Kim BS, Kim YH, Kim JS. Seo HY, et al. Among authors: kim yh, kim bs, kim sj, kim js. Jpn J Clin Oncol. 2010 Dec;40(12):1147-53. doi: 10.1093/jjco/hyq111. Epub 2010 Jul 20. Jpn J Clin Oncol. 2010. PMID: 20647232

9

Is chemotherapy in elderly patients with metastatic or recurrent gastric cancer as tolerable and effective as in younger patients?

Kim ST, Park KH, Oh SC, Seo JH, Shin SW, Kim JS, Kim YH. Kim ST, et al. Among authors: kim yh, kim js. Asia Pac J Clin Oncol. 2012 Jun;8(2):194-200. doi: 10.1111/j.1743-7563.2011.01501.x. Epub 2012 Mar 12. Asia Pac J Clin Oncol. 2012. PMID: 22524579

10

A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy.

Kim YH, Muro K, Yasui H, Chen JS, Ryu MH, Park SH, Chu KM, Choo SP, Sanchez T, DelaCruz C, Mukhopadhyay P, Lainas I, Li CP. Kim YH, et al. Cancer Chemother Pharmacol. 2012 Oct;70(4):583-90. doi: 10.1007/s00280-012-1943-6. Epub 2012 Aug 12. Cancer Chemother Pharmacol. 2012. PMID: 22886073 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,821 results

Search Page

Filters